Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

344

HTML

3203

Figures (1-5)

127

Sum=3674

Apr 15, 2003 (publication date) through Apr 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Apr 15, 2003; 9(4): 696-700
Published online Apr 15, 2003. doi: 10.3748/wjg.v9.i4.696

Full Size Figure Download Figure

Figure 1 The survival fraction of SMMC-7721 cells treated with docetaxel for 24 hr.

Citation: Geng CX, Zeng ZC, Wang JY. Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosis. World J Gastroenterol 2003; 9(4): 696-700
URL: https://www.wjgnet.com/1007-9327/full/v9/i4/696.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i4.696